Skip to content
healthcare.dev

Sinu-Rite

NDC 68703-357, Glycyrrhiza, Kali bic, Nat mur, Pulsatilla, Sambucus, tablet, from SILVER STAR BRANDS.

Product NDC
68703-357
Status
Listed
Labeler
SILVER STAR BRANDS
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68703-357 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GLYCYRRHIZA GLABRA6 [hp_X]/1801
  • SODIUM CHLORIDE6 [hp_X]/1801
  • POTASSIUM DICHROMATE30 [hp_C]/1801
  • SAMBUCUS NIGRA FLOWER6 [hp_X]/1801
  • PULSATILLA VULGARIS30 [hp_C]/1801

Pharmacologic classes

Allergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]; Non-Standardized Food Allergenic Extract [EPC]; Non-Standardized Plant Allergenic Extract [EPC]; Plant Proteins [CS]

Package NDCNDC-11Package
68703-357-8068703035780180 TABLET in 1 BOTTLE, GLASS (68703-357-80)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 68703-357 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68703-357 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68703-357. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.